Which of the following factors can trigger malignant hyperthermia in susceptible individuals?

Choice A rationale Over-hydration or the administration of corticosteroid medications does not have a known physiological link to the triggering of malignant hyperthermia. This condition is a pharmacogenetic disorder of skeletal muscle calcium homeostasis. Steroids do not interact with the ryanodine receptor (RYR1) in a manner that would precipitate the massive release of calcium from the sarcoplasmic reticulum. Consequently, these substances do not cause the hypermetabolic state characterized by muscle rigidity, hypercapnia, and dangerous temperature elevations. Choice B rationale Local anesthetics, such as lidocaine or bupivacaine, are not considered triggering agents for malignant hyperthermia according to modern clinical guidelines. While older medical theories once suggested a possible link, extensive scientific research has confirmed that these amide or ester local anesthetics are safe for use in susceptible individuals. The pathophysiology of malignant hyperthermia specifically requires exposure to potent volatile gases or certain depolarizing muscle relaxants to initiate the rapid and uncontrolled muscle metabolism. Choice C rationale Inhalation anesthetics including isoflurane, sevoflurane, and desflurane are primary triggers for malignant hyperthermia in genetically predisposed individuals. These halogenated agents act on the ryanodine receptors within skeletal muscle cells, causing an uncontrolled efflux of calcium. This results in sustained muscle contractions and a dramatic increase in metabolic rate. The clinical consequences include rapid depletion of adenosine triphosphate, excessive carbon dioxide production, and severe metabolic acidosis, which can be fatal if the administration of dantrolene is delayed. Choice D rationale Opioid medications used for perioperative pain management, such as fentanyl or morphine, do not trigger the biochemical cascade associated with malignant hyperthermia. These medications act primarily on the central nervous system to modulate pain perception and do not affect the calcium release channels in skeletal muscle fibers. Clinicians routinely use opioids as part of a balanced anesthesia plan for patients known to be susceptible to malignant hyperthermia because they provide effective analgesia without risking a hypermetabolic crisis.